Figure 1.
Cumulative incidence of biochemical recurrence (BCR) of prostate cancer after salvage radiation therapy (SRT) for patients with low (≤9.0 mg/dL), moderate (>9.0 and ≤9.35 mg/dL), and high (>9.35 mg/dL) pre-SRT serum calcium levels.
Cumulative incidence of biochemical recurrence (BCR) of prostate cancer after salvage radiation therapy (SRT) for patients with low (≤9.0 mg/dL), moderate (>9.0 and ≤9.35 mg/dL), and high (>9.35 mg/dL) pre-SRT serum calcium levels.